Information
-
Trademark
-
88227612
-
International Classifications
-
Filing Date
December 13, 2018
6 years ago
-
Transaction Date
May 22, 2019
5 years ago
-
Status Date
May 21, 2019
5 years ago
-
Published for Opposition Date
April 16, 2019
5 years ago
-
Location Date
May 21, 2019
5 years ago
-
Status Code
605
-
Current Location
GENERIC WEB UPDATE
Employee Name
NADELMAN, ANDREA KOYNE
-
Law Office Assigned Location Code
M10
-
Owners
Mark Drawing Code
4000
Mark Identification
KYRINA
Case File Statements
- GS0051: Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications
Case File Event Statements
-
5/21/2019 - 5 years ago
10 - ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Type: MAB5
-
5/21/2019 - 5 years ago
9 - ABANDONMENT - AFTER PUBLICATION
Type: ABN5
-
5/15/2019 - 5 years ago
8 - TEAS EXPRESS ABANDONMENT RECEIVED
Type: EXAR
-
4/16/2019 - 5 years ago
7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
4/16/2019 - 5 years ago
6 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
3/27/2019 - 5 years ago
5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
3/8/2019 - 5 years ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/8/2019 - 5 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/5/2019 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
12/17/2018 - 6 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP